http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009150323-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fa9bb2190af449d4431602b76e47727
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
filingDate 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e8703338cfb105e2f4911f1913d0d7
publicationDate 2009-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009150323-A1
titleOfInvention Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix
abstract The present invention relates to use of a matrix for the oral administration, in tablet form, of gradual continuous release Mg provided with a protective coating slowing down the gastric dissolution of the Mg, said matrix being characterized in that it includes, for the administration (A) of 90 to 110 parts by weight of magnesium, the following ingredients: (B1) 180 to 190 parts by weight of hydroxypropylmethyl cellulose; (B2) 19.8 to 22.2 parts by weight of glyceryl behenate; (C1) 10 to 12 parts by weight of lactose; and (C2) 10 to 12 parts by weight of colloidal silica. The invention also relates to the gradual release composition including said matrix and the coating thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2813217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018127594-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10457635-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014198591-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3345591-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017214391-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10653718-B2
priorityDate 2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005220865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005266082-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004156896-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128916092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129381420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127776308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127754342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136230068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128555702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23623894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977

Total number of triples: 75.